Acorda Therapeutics Announces Agreement for Sale of Manufacturing Operations and Long-Term Global Supply Agreement for INBRIJA®, Corporate Restructuring, and Enters into “At The Market” Offering Agreement
$80 million up-front payment will substantially increase cash balance Sale, restructuring and other operating expense…
Cregis Shines at Paris Blockchain Week 2026, Accelerating European Expansion